FDA Advisers Vote Against Lexicon Pharma's Add-on Drug for Type 1 Diabetes

Independent advisers to the U.S. Food and Drug Administration on Thursday voted against recommending Lexicon Pharmaceuticals' add-on treatment to insulin therapy for...
Reuters Health Information

source https://www.medscape.com/s/viewarticle/fda-advisers-vote-against-lexicon-pharmas-add-drug-type-1-2024a1000k00?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?

RA and RA-ILD Linked to Higher Lung Cancer Risk